Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated?
Feit
F
F
Cardiac Catheterization and Interventional Cardiology, New York University School of Medicine, 560 First Avenue, New York, NY 10016, USA. frederick.feit@med.nyu.edu.
Bittl
J A
JA
Keller
N M
NM
Attubato
M J
MJ
Weitz
J I
JI
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects; D000991:Antithrombins / Q000627:therapeutic use; D006470:Hemorrhage / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D015994:Incidence; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors
D000925:Anticoagulants; D000991:Antithrombins; D006493:Heparin